Search

everythinglearnresearchcommunity

for

Search:↓

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Accurate diagnosis of granular parakeratosis is crucial for effective treatment and improvement.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Mice with human skin protein K8 had more skin problems and cancer.

Disrupting Smad4 in mouse skin causes early hair follicle stem cell activity that leads to their eventual depletion.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

NGAL may help maintain skin balance and is linked to skin disorders and cancers.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

A woman had 13 non-cancerous cysts on her scalp successfully removed in one surgery.